BATS BZX Real-Time Price
As of 10:22am ET
| +0.79 / +1.49%|
The 5 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 57.00, with a high estimate of 60.00 and a low estimate of 53.00. The median estimate represents a +5.75% increase from the last price of 53.90.
The current consensus among 6 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.